(Watch the video interview HERE)
In this video, Vox Markets talks to Clarissa Sowemimo-Coker, CEO of
Oxford Cannabinoid (OCTP), a biotech company focused on developing prescription medications from cannabinoids, taking Vox through the company's mission to address unmet patient needs, particularly within the US multi-billion dollar pain market. They announce their expansion into oncology and the potential of a first-in-class oral immunotherapy for solid tumors.